Till­man Gern­gross makes it of­fi­cial: He's out as CEO as trou­bled Ada­gio vows to sol­dier on

The oth­er shoe has dropped at Ada­gio.

On Wednes­day evening, the com­pa­ny put out a re­lease say­ing that found­ing CEO Till­man Gern­gross, a high pro­file fig­ure in the an­ti­body world, had re­signed — con­firm­ing an ear­li­er SEC fil­ing that he had agreed to leave. In his place, the board ap­point­ed COO David Her­ing to the in­ter­im CEO job, while launch­ing a search for a new chief.

The board went on to praise Gern­gross for cre­at­ing a strong foun­da­tion at the com­pa­ny, which in­cludes a cush­ion of cash af­ter rais­ing more than $800 mil­lion in a lit­tle more than a year while tak­ing the com­pa­ny pub­lic $AD­GI.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER